查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611415

皮肤癌皮肤科市场：按检查、年龄层、设施类型 - 2025-2030 年全球预测

Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年皮肤癌皮肤科市场价值为77.8亿美元，预计到2024年将达到84.2亿美元，复合年增长率为7.40%，到2030年将达到128.3亿美元。

皮肤癌皮肤科市场的范围涵盖预防、诊断和治疗技术，包括手术、局部和全身治疗。由于人口老化、紫外线照射增加和臭氧层消耗，全球皮肤癌发生率不断增加，因此这个市场至关重要。市场应用多种多样，包括製药、生物技术、医院、皮肤科诊所和研究机构。最终用途范围从患者诊断到量身定制的治疗性介入。主要成长动力包括人工智慧诊断等技术进步、医疗保健意识的提高以及政府对早期检测的支持。此外，创新的局部和免疫疗法的商业化提供了潜在的机会，特别是在个人化医疗领域。为了抓住这些机会，公司应该投资数位皮肤健康监测工具和人工智慧主导的诊断平台。然而，高昂的治疗成本、监管障碍和保险报销的复杂性等限制因素对市场成长构成了挑战。在发展中地区，意识低落和医疗基础设施有限是额外的障碍。创新成长领域包括非侵入性诊断技术，例如光同调断层扫瞄和新型光保护剂的开发。标靶治疗的遗传和分子生物学研究和开发也可能推动市场开拓。对远距皮肤病学和家庭皮肤癌筛检工具的见解凸显了市场向偏远地区个人化患者照护的转变。市场竞争激烈，主要企业在积极进行併购以增强其产品组合。由于医疗保健领域的研发投资和数位转型的增加，该市场具有强劲的成长潜力，但企业需要驾驭这一格局，并在充满挑战但充满活力的市场中做好定位，我们需要解决当前的限制并关注监管环境。

主要市场统计
基准年[2023] 77.8亿美元
预计年份 [2024] 84.2亿美元
预测年份 [2030] 128.3亿美元
复合年增长率（%） 7.40%

市场动态：快速发展的皮肤癌皮肤病学市场的关键市场洞察

供需的动态交互作用正在改变皮肤癌皮肤科市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球皮肤癌发生率增加
    • 先进医疗基础设施的可用性
    • 人们对皮肤癌的认识不断增强
  • 市场限制因素
    • 治疗费用上涨
  • 市场机会
    • 随着远距皮肤病学的引入不断发展
    • 智慧型手机相容诊断设备的增加
  • 市场挑战
    • 严格的核准和处理法律规范

波特五力：驾驭皮肤癌皮肤科市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解皮肤癌皮肤科市场的外部影响

外部宏观环境因素在塑造皮肤癌皮肤病学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解皮肤癌皮肤科市场的竞争状况

皮肤癌皮肤病学市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵皮肤癌皮肤科市场供应商的绩效评估

FPNV 定位矩阵是评估皮肤癌皮肤科市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了皮肤癌皮肤科市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对皮肤癌皮肤科市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球皮肤癌发生率上升
      • 先进医疗基础设施的可用性
      • 大众对皮肤癌的认识提高
    • 抑制因素
      • 资本集中治疗和疗法
    • 机会
      • 透过引入远距皮肤病学持续发展
      • 智慧型手机相容诊断设备的增加
    • 任务
      • 严格的核准和处理法规结构
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章皮肤癌皮肤科市场测试

  • 皮肤镜检查
  • 诊断影像
  • 淋巴结活检
  • 皮肤切片检查

第七章皮肤癌皮肤科市场：依年龄组

  • 0-19
  • 20-39
  • 40-59
  • 60-64
  • 65-74
  • 75-84
  • 85岁以上

第八章按设施类型分類的皮肤癌皮肤科市场

  • 皮肤科组
  • 医院门诊
  • 多学科诊所
  • 独立实践

第九章北美和南美皮肤癌皮肤科市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太皮肤癌皮肤科市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲皮肤癌皮肤科市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Amgen, Inc.
  • Bristol-Myers Squibb Company
  • Canfield Scientific, Inc.
  • Colleyville Dermatology
  • Cutera, Inc.
  • FotoFinder Systems, Inc.
  • Merck & Co., Inc.
  • MetaOptima Technology Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi SA
  • Skin Analytics Pty Ltd.
  • Speclipse, Inc.
  • Sun Pharmaceutical Industries Limited
Product Code: MRR-0360AB17E0FA

The Skin Cancer Dermatology Market was valued at USD 7.78 billion in 2023, expected to reach USD 8.42 billion in 2024, and is projected to grow at a CAGR of 7.40%, to USD 12.83 billion by 2030.

The scope of the skin cancer dermatology market encompasses prevention, diagnosis, and treatment technologies, including surgical, topical, and systemic therapies. It is essential due to the rising incidence of skin cancer globally, driven by aging populations, increased UV exposure, and ozone layer depletion. The market applications range across pharmaceutical and biotechnological sectors, hospitals, dermatology clinics, and research institutions. End-use scope extends from patient diagnostics to tailored therapeutic interventions. Key growth drivers include technological advancements like AI in diagnostics, increased healthcare awareness, and supportive government initiatives for early detection. Furthermore, the commercialization of innovative topical therapies and immunotherapies presents potential opportunities, particularly in the personalized medicine domain. To seize these opportunities, companies should invest in digital skin health monitoring tools and AI-driven diagnostic platforms. However, limitations such as high treatment costs, regulatory hurdles, and the complexity of insurance reimbursements challenge market growth. In developing regions, the lack of awareness and limited healthcare infrastructure pose additional barriers. Innovative areas for growth include non-invasive diagnostic technologies, such as optical coherence tomography, and the development of novel photoprotective agents. Exploring genetic and molecular research for targeted therapies could also propel market developments. Insights into teledermatology and home-based skin cancer screening tools highlight the market's shift towards remote and personalized patient care. The nature of the market is highly competitive, with key players actively engaging in mergers and acquisitions to enhance their portfolios. While the market offers robust growth potential due to increased R&D investments and healthcare's digital transformation, companies must address current limitations and focus on regulatory compliance to successfully navigate this landscape and position themselves advantageously in a market that is as dynamic as it is challenging.

KEY MARKET STATISTICS
Base Year [2023] USD 7.78 billion
Estimated Year [2024] USD 8.42 billion
Forecast Year [2030] USD 12.83 billion
CAGR (%) 7.40%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Skin Cancer Dermatology Market

The Skin Cancer Dermatology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of skin cancer worldwide
    • Availability of advanced healthcare infrastructure
    • Rising awareness about skin cancer among the population
  • Market Restraints
    • Capital intensive treatment with therapy
  • Market Opportunities
    • Ongoing development with introduction of teledermatology
    • Increasing number of smartphone-compatible diagnostic devices
  • Market Challenges
    • Strict regulatory framework for the approval and treatment

Porter's Five Forces: A Strategic Tool for Navigating the Skin Cancer Dermatology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Skin Cancer Dermatology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Skin Cancer Dermatology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Skin Cancer Dermatology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Skin Cancer Dermatology Market

A detailed market share analysis in the Skin Cancer Dermatology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Skin Cancer Dermatology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Skin Cancer Dermatology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Skin Cancer Dermatology Market

A strategic analysis of the Skin Cancer Dermatology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Skin Cancer Dermatology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Canfield Scientific, Inc., Colleyville Dermatology, Cutera, Inc., FotoFinder Systems, Inc., Merck & Co., Inc., MetaOptima Technology Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Skin Analytics Pty Ltd., Speclipse, Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Skin Cancer Dermatology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test, market is studied across Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy, and Skin Biopsy.
  • Based on Age Group, market is studied across 0-19, 20-39, 40-59, 60-64, 65-74, 75-84, and 85 & Above.
  • Based on Facility Type, market is studied across Dermatology Group, Hospital OPD, Multispecialty Clinics, and Stand Alone Practices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of skin cancer worldwide
      • 5.1.1.2. Availability of advanced healthcare infrastructure
      • 5.1.1.3. Rising awareness about skin cancer among the population
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive treatment with therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development with introduction of teledermatology
      • 5.1.3.2. Increasing number of smartphone-compatible diagnostic devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework for the approval and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Skin Cancer Dermatology Market, by Test

  • 6.1. Introduction
  • 6.2. Dermatoscopy
  • 6.3. Diagnostic Imaging
  • 6.4. Lymph Node Biopsy
  • 6.5. Skin Biopsy

7. Skin Cancer Dermatology Market, by Age Group

  • 7.1. Introduction
  • 7.2. 0-19
  • 7.3. 20-39
  • 7.4. 40-59
  • 7.5. 60-64
  • 7.6. 65-74
  • 7.7. 75-84
  • 7.8. 85 & Above

8. Skin Cancer Dermatology Market, by Facility Type

  • 8.1. Introduction
  • 8.2. Dermatology Group
  • 8.3. Hospital OPD
  • 8.4. Multispecialty Clinics
  • 8.5. Stand Alone Practices

9. Americas Skin Cancer Dermatology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Skin Cancer Dermatology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Skin Cancer Dermatology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amgen, Inc.
  • 3. Bristol-Myers Squibb Company
  • 4. Canfield Scientific, Inc.
  • 5. Colleyville Dermatology
  • 6. Cutera, Inc.
  • 7. FotoFinder Systems, Inc.
  • 8. Merck & Co., Inc.
  • 9. MetaOptima Technology Inc.
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Regeneron Pharmaceuticals, Inc.
  • 13. Sanofi S.A.
  • 14. Skin Analytics Pty Ltd.
  • 15. Speclipse, Inc.
  • 16. Sun Pharmaceutical Industries Limited

LIST OF FIGURES

  • FIGURE 1. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. SKIN CANCER DERMATOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SKIN CANCER DERMATOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SKIN CANCER DERMATOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY LYMPH NODE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SKIN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 0-19, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 20-39, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 40-59, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 60-64, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 65-74, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 75-84, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY 85 & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY GROUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL OPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY STAND ALONE PRACTICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023